MWM
ABBV icon

Maridea Wealth Management’s AbbVie ABBV Stock Holding History

Maridea Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$636K Buy
2,526
+868
+52% +$187K 0.07% 257
2026
Q1 		$361K Buy
1,658
+133
+9% +$29.5K 0.05% 306
2025
Q4 		$349K Sell
1,525
-614
-29% -$140K 0.05% 311
2025
Q3 		$496K Buy
2,139
+678
+46% +$138K 0.08% 250
2025
Q2 		$271K Buy
+1,461
New +$272K 0.07% 227

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Maridea Wealth Management's ABBV Position: Q2 2026 in Review

Maridea Wealth Management increased its AbbVie (ABBV) stake by 52% in Q2 2026, buying an estimated $187K and bringing the position to 2,526 shares worth $636K. The position accounts for 0.07% of the portfolio, ranked #257.

Maridea Wealth Management first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Maridea Wealth Management held 2,526 shares of AbbVie worth $636K as of Q2 2026.
  • Maridea Wealth Management bought 868 AbbVie shares in Q2 2026, an estimated $187K.
  • AbbVie made up 0.07% of Maridea Wealth Management's portfolio in Q2 2026, its #257 holding.
  • Maridea Wealth Management first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Maridea Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.